CCA
AMGN icon

Cypress Capital Advisors’s Amgen AMGN Stock Holding History

Cypress Capital Advisors’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.11M Sell
3,141
-38
-1% -$13.5K 0.6% 27
2025
Q4 		$1.04M Sell
3,179
-24
-0.7% -$7.61K 0.56% 30
2025
Q3 		$904K Sell
3,203
-213
-6% -$61.8K 0.51% 38
2025
Q2 		$954K Buy
3,416
+34
+1% +$9.63K 0.6% 32
2025
Q1 		$1.05M Buy
3,382
+61
+2% +$18K 0.73% 27
2024
Q4 		$866K Buy
+3,321
New +$985K 0.68% 34

Other funds holding AMGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Cypress Capital Advisors's AMGN Position: Q1 2026 in Review

Cypress Capital Advisors reduced its Amgen (AMGN) stake by 1.2% in Q1 2026, selling an estimated $13.5K and leaving 3,141 shares worth $1.11M. The position accounts for 0.6% of the portfolio, ranked #27.

Cypress Capital Advisors first reported a position in AMGN in Q4 2024 and has held it in 6 quarters since. 3,127 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Cypress Capital Advisors held 3,141 shares of Amgen worth $1.11M as of Q1 2026.
  • Cypress Capital Advisors sold 38 Amgen shares in Q1 2026, an estimated $13.5K.
  • Amgen made up 0.6% of Cypress Capital Advisors's portfolio in Q1 2026, its #27 holding.
  • Cypress Capital Advisors first reported a position in Amgen in Q4 2024 and has held it in 6 quarters since.
  • 3,127 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Cypress Capital Advisors's 13F filing for Q1 2026, filed 21 Apr 2026.